Immunotherapy Makes History with Latest Cancer Approval May 23, 2017December 14, 2022 Arthur N. Brodsky, PhD
FDA approves Keytruda combo for first-line lung cancer treatment May 12, 2017December 14, 2022 Arthur N. Brodsky, PhD
Durvalumab Becomes Newest Immunotherapy Approved for Advanced Bladder Cancer May 5, 2017December 14, 2022 Arthur N. Brodsky, PhD
Atezolizumab approved as first-line therapy for chemotherapy-ineligible bladder cancer patients April 20, 2017December 14, 2022 Arthur N. Brodsky, PhD